IP Library Granted Patent US 9,731,132
Granted Patent B2
US 9,731,132 · App. 15/254,340 · Granted Aug 15, 2017

Methods for renal neuromodulation

Inventors: Mark Deem (Mountain View, CA); Denise Zarins (Saratoga, CA); Douglas Sutton (Pacifica, CA); Hanson Gifford, III (Woodside, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY); Benjamin J. Clark (Redwood City, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61N1/36117A61B18/1492A61N1/0551A61N1/32A61N1/327A61N1/36007A61N1/36017A61N1/36128A61N5/00A61B2018/00267A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00613A61B2018/00702A61B2018/00779A61B2018/00791A61B2018/00875A61B2018/00982A61B2018/1435
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,731,132
App. No.
15/254,340
Granted
Aug 15, 2017
Kind
B2
Abstract

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

Claims (17)

1. A method for reducing blood pressure in a human patient, the method comprising:

implanting a neural stimulation system in the patient below the patient's skin, wherein the neural stimulation system includes an electric field generator electrically coupled to a ring-shaped electrode positioned adjacent to target renal nerves innervating a kidney of the patient; and

delivering generated electrical signals from the electric field generator to the target nerves via the ring-shaped electrode, thereby altering the naturally occurring neural signals propagating through the nerves,

wherein delivering the generated electrical signals to the target nerves of the patient results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 wherein delivering generated electrical signals from the electric field generator to the target nerves via the ring-shaped electrode comprises delivering generated stimulation signals to the target nerves.

3. The method of claim 1 wherein delivering generated electrical signals from the electric field generator to the target nerves via the ring-shaped electrode comprises delivering at least two different levels of generated stimulation signals to the target nerves.

4. The method of claim 1 wherein delivering generated electrical signals from the electric field generator to the target nerves via the ring-shaped electrode comprises delivering intermittent stimulation to the target nerves.

5. The method of claim 1 wherein delivering generated electrical signals from the electric field generator to the target nerves via the ring-shaped electrode comprises delivering the electrical signals in a unipolar fashion.

6. The method of claim 1 wherein altering the naturally occurring neural signals propagating through the nerves comprises attenuating the neural signals along the target nerves.

7. The method of claim 1 wherein the ring-shaped electrode adjacent to the renal nerves at least partially surrounds a renal blood vessel of the patient.

8. The method of claim 1 wherein delivering generated electrical signals from the electric field generator to the target nerves via the ring-shaped electrode comprises decreasing renal sympathetic nerve activity of the patient.

9. The method of claim 1 , further comprising monitoring at least one physiologic parameter of the patient with a sensor.

10. The method of claim 9 , further comprising transmitting information regarding the monitored physiologic parameter from the sensor to a device located outside of the patient.

11. The method of claim 10 wherein the monitored physiologic parameter comprises at least one of blood pressure, renin levels, sodium levels, and renal blood flow.

12. The method of claim 10 wherein the monitored physiologic parameter is indicative of renal activity.

13. The method of claim 1 wherein the neural stimulation system further comprises an energy storage device electrically coupled to the electric field generator, and wherein the electric field generator is configured for recharging via the energy storage device.

14. The method of claim 1 wherein the neural stimulation system is configured to be reprogrammed after implantation in the patient.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2017
From: ZARINS, DENISE; DEEM, MARK; SUTTON, DOUGLAS; GIFFORD, HANSON, III; LEVIN, HOWARD R.; GELFAND, MARK; CLARK, BENJAMIN J.
To: ARDIAN, INC.
Reel/Frame 042725/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2017
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 042725/0824 →
CHANGE OF NAME Recorded Jun 15, 2017
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 042827/0496 →
Continuity (14)
Continuation 14878898 · Oct 8, 2015
Continuation 14279023 · May 15, 2014
Continuation 13942223 · Jul 15, 2013
Continuation 13361542 · Jan 30, 2012
Division 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20170080230A1 · Mar 23, 2017